Changhong Technology

Changhong Technology, formally Shenzhen Changhong Technology Co., Ltd., is a Chinese industrial manufacturing company specializing in plastic components, injection molds, tooling, and related precision-production services. The company operates from Shenzhen, Guangdong, and has subsidiaries or operating entities in Shenzhen, Shanghai, Heyuan, Anhui, and Hong Kong. Its business is primarily industrial and business-to-business rather than consumer-facing: it supplies molded parts and tooling used in office equipment, medical and laboratory products, consumer electronics, and other manufactured goods. The company’s corporate history reflects a progression from hardware manufacturing into mold technology and then into a broader technology and component-manufacturing identity. It was originally known as Shenzhen Changhong Hardware Manufacture Co., Ltd. On 20 December 2007, it changed its name to Shenzhen Changhong Mold Technology Co., Ltd., a change associated with the increasing importance of tooling and mold production. On 15 May 2012, it adopted the name Shenzhen Changhong Technology Co., Ltd., reflecting a further expansion in the description of its business activities. The company also relocated on 16 December 2005 from Jianxin Village in Ailian Village, Longgang Town, Shenzhen, to premises on the west side of Jinlong Avenue in what became Pingshan New District. Changhong Technology became a publicly traded company on 22 December 2010, when its shares were listed on the Shenzhen Stock Exchange’s ChiNext board under stock code 300151. Its listing was financed through cash contributions from company insiders and outside investors. Chairman Li Huanchang supplied the largest reported individual contribution, while managers associated with the Heyuan and Shanghai operations also invested. Venture-capital investors and other shareholders provided the balance. The listing gave the company access to public capital while retaining a strong connection between management and ownership. The company’s customer base has included multinational and Chinese manufacturers. The cited customer list includes Konica Minolta, Brother Industries, Thermo Fisher, and Beijing Xiaomi Technology. For office-equipment customers such as Konica Minolta and Brother, Changhong Technology has produced tooling and plastic parts for multifunction printers. Its relationships with Thermo Fisher and Xiaomi indicate a broader role as a contract and component supplier serving medical, laboratory, electronics, and consumer-technology production chains. The company’s manufacturing proposition is therefore based on engineering capability, mold development, production precision, and the ability to supply components to established original-equipment manufacturers. Expansion beyond conventional tooling also involved the medical-products sector. In 2015, Changhong Technology acquired a 79.75% stake in Lingen Precision Medical Products (Shanghai) Co. Ltd. for approximately CN¥67.79 million. The investment was intended to broaden the group’s exposure to precision medical products, but Lingen subsequently failed to meet revenue targets. In 2018, Changhong Technology decided not to pursue compensation from Lingen founder Zhu Dexin, citing his illness. The decision drew criticism from shareholders and regulatory scrutiny, making the transaction one of the most publicly discussed episodes in the company’s history. As of 9 November 2016, Changhong Technology was reported as a constituent of the SZSE 1000 Index and the SZSE 700 Index, although it was not included in the SZSE Component Index. This placed it among companies ranked approximately from 501st to 1,000th by free-float-adjusted market capitalization at that time. The available reference material does not provide current operating figures, financial results, leadership information, or a current official website, so those details are left unreported here.

Changhong Technology is a Shenzhen-based Chinese industrial manufacturer whose business developed from hardware production into mold-making, plastic-component manufacturing, and related precision products. The company’s earlier corporate name was Shenzhen Changhong Hardware Manufacture Co., Ltd. On 20 December 2007, it became Shenzhen Changhong Mold Technology Co., Ltd., emphasizing mold and tooling capabilities. On 15 May 2012, it adopted its current name, Shenzhen Changhong Technology Co., Ltd., as its business scope expanded beyond a narrowly defined mold-making identity. The company moved from Jianxin Village in Ailian Village, Longgang Town, Shenzhen, to premises on the west side of Jinlong Avenue in Pingshan New District on 16 December 2005. Its headquarters are in Pingshan, and the wider CHT Group has operating entities or subsidiaries in Shenzhen, Shanghai, Heyuan, Anhui, and Hong Kong. This geographic structure supports production and customer-service activities across several Chinese manufacturing centers, with Hong Kong included in the group’s reported corporate footprint. Changhong Technology entered the public markets on 22 December 2010 through a listing on the Shenzhen Stock Exchange ChiNext board. The shares trade under code SZSE: 300151. The listing was supported by cash investment from company insiders and external investors. Chairman Li Huanchang was reported to have provided the largest individual contribution, while Heyuan subsidiary general manager Hua Shoufu and Shanghai subsidiary general manager Xu Yanping also participated. Venture investors, including Shenzhen Zhongke Hongyi Venture Investment Co. and Zhejiang Lianheng Venture Capital Co., and other investors supplied the remaining capital. The public listing formalized the company’s access to equity markets while preserving substantial participation by management-linked investors. Its core operating model is business-to-business manufacturing. Changhong Technology produces injection molds, tooling, and plastic parts for industrial customers. Major reported customers include Konica Minolta and Brother Industries, for which the company makes tooling and components associated with multifunction printers. Thermo Fisher and Beijing Xiaomi Technology have also been identified among its customers, suggesting that the company’s production capabilities serve laboratory, medical, electronics, and consumer-technology supply chains. Rather than selling a widely marketed consumer product under its own name, Changhong Technology functions mainly as an engineering, tooling, and component partner to larger manufacturers. The company pursued diversification through a medical-products investment in 2015, acquiring 79.75% of Lingen Precision Medical Products (Shanghai) Co. Ltd. for approximately CN¥67.79 million. The transaction extended the group’s interests into precision medical products, but Lingen later failed to meet revenue targets. In 2018, Changhong Technology chose not to seek compensation from Lingen founder Zhu Dexin, referring to his illness. Shareholders criticized the decision, and the matter attracted regulatory scrutiny. It is the principal controversy identified in the available reference material. The company was included in the SZSE 1000 and SZSE 700 indexes as of 9 November 2016, but not in the SZSE Component Index. The available material does not establish its current index membership, financial performance, current executives, official website, or present operating scale. Accordingly, this dossier describes the documented historical business and corporate events without extending unsupported claims about its current position.

• 2018

  Decision not to pursue Lingen compensation

  [1]Changhong Technologyen.wikipedia.org

  The company decided not to seek compensation from Lingen founder Zhu Dexin after missed revenue targets, citing his illness.

• 2016

  Reported inclusion in SZSE indexes

  [1]Changhong Technologyen.wikipedia.org

  As of 9 November, the company was reported as a constituent of the SZSE 1000 and SZSE 700 indexes.

• 2015

  Majority investment in Lingen Precision Medical Products

  [1]Changhong Technologyen.wikipedia.org

  Changhong Technology acquired a 79.75% interest in Lingen Precision Medical Products (Shanghai) Co. Ltd.

• 2012

  Adoption of current corporate name

  [1]Changhong Technologyen.wikipedia.org

  The company changed its name to Shenzhen Changhong Technology Co., Ltd. on 15 May.

• 2010

  ChiNext listing

  [1]Changhong Technologyen.wikipedia.org

  Changhong Technology listed on the Shenzhen Stock Exchange ChiNext board under stock code 300151 on 22 December.

• 2007

  Name changed to Shenzhen Changhong Mold Technology

  [1]Changhong Technologyen.wikipedia.org

  The company changed its name from Shenzhen Changhong Hardware Manufacture Co., Ltd., reflecting a stronger focus on mold and tooling technology.

• 2005

  Relocation to Pingshan

  [1]Changhong Technologyen.wikipedia.org

  The company relocated from Jianxin Village in Ailian Village, Longgang Town, Shenzhen, to premises on the west side of Jinlong Avenue in Pingshan New District.

A business-to-business precision manufacturing and component supplier focused on injection molding, tooling, plastic parts, and selected medical-product applications.

• Industrial tooling

  Injection molds and tooling

  Changhong Technology’s documented core activity is the development and manufacture of injection molds and related tooling. These products support repeatable production of plastic parts for original-equipment manufacturers. The company’s tooling has been associated with multifunction-printer production for customers including Konica Minolta and Brother Industries.

• Plastic components

  Precision plastic parts

  The company produces molded plastic parts for industrial and technology customers. These components are supplied through business-to-business manufacturing relationships rather than primarily marketed as consumer products. Reported applications span office equipment, electronics, laboratory products, and other manufactured goods.

• Medical manufacturing · 2015

  Medical-product components

  Changhong Technology expanded into precision medical products through its 2015 majority acquisition of Lingen Precision Medical Products (Shanghai) Co. Ltd. The available reference does not provide a detailed catalog of Lingen products, so this entry is limited to the documented medical-manufacturing activity.

• 2018

  Controversy over waived compensation related to Lingen

  After Lingen Precision Medical Products failed to meet revenue targets, Changhong Technology decided not to seek compensation from founder Zhu Dexin, citing his illness. Shareholders criticized the decision, and regulators scrutinized the matter.

  Source

Read more

• 2018

  Decision not to seek compensation from Lingen founderOther

  Background

  Lingen did not meet its revenue targets after Changhong Technology’s majority investment. The company cited the illness of founder Zhu Dexin.

  Action taken

  Changhong Technology chose not to seek compensation from Zhu Dexin.

  Aftermath

  The decision drew shareholder criticism and regulatory scrutiny.

  Source

• 2015

  Acquisition of Lingen Precision Medical ProductsM&A

  Background

  Changhong Technology pursued diversification into precision medical products.

  Action taken

  It acquired a 79.75% stake in Lingen Precision Medical Products (Shanghai) Co. Ltd.

  Aftermath

  Lingen later failed to meet revenue targets, and the subsequent decision regarding compensation became controversial.

  Acquisition consideration. CN¥67.79 million (2015)

  Source

• 2012

  Adoption of the Changhong Technology nameStrategy

  Background

  The company’s activities had broadened beyond the narrower mold-technology description.

  Action taken

  It changed its name to Shenzhen Changhong Technology Co., Ltd. on 15 May.

  Aftermath

  The current name presents the company as a broader technology and manufacturing enterprise.

  Source

• 2010

  Public-market listingOther

  Background

  Changhong Technology sought public equity-market access to support its corporate development and manufacturing activities.

  Action taken

  The company listed on the Shenzhen Stock Exchange ChiNext board under stock code 300151 on 22 December.

  Aftermath

  The listing made Changhong Technology a publicly traded manufacturing company.

  Source

• 2007

  Shift in corporate identity toward mold technologyStrategy

  Background

  The company’s original hardware-manufacturing name no longer fully represented its developing tooling and mold-making activities.

  Action taken

  It changed its name to Shenzhen Changhong Mold Technology Co., Ltd.

  Aftermath

  The company later adopted the broader Changhong Technology name in 2012.

  Source

• 2016

  Changhong Technology joins the SZSE 1000 and SZSE 700 indexes[1]Changhong Technologyen.wikipedia.org

  Other

  As of 9 November 2016, Changhong Technology was reported as a constituent of the SZSE 1000 Index and SZSE 700 Index, but not the SZSE Component Index.

• 2015

  Changhong Technology acquires a majority stake in Lingen Precision Medical Products[1]Changhong Technologyen.wikipedia.org

  M&A

  The company acquired 79.75% of Lingen Precision Medical Products (Shanghai) Co. Ltd. for approximately CN¥67.79 million, expanding into precision medical products.

• 2012

  Changhong Technology changes its corporate name to reflect broader activities[1]Changhong Technologyen.wikipedia.org

  Other

  The company changed its name from Shenzhen Changhong Mold Technology Co., Ltd. to Shenzhen Changhong Technology Co., Ltd. on 15 May 2012.

• 2010

  Changhong Technology lists on the Shenzhen Stock Exchange ChiNext board[1]Changhong Technologyen.wikipedia.org

  Other

  Changhong Technology was listed on 22 December 2010 under stock code SZSE: 300151.

1. 1Changhong Technologyen.wikipedia.org
2. 2CHT Group acquires keimadditec surfacechemeurope.com